Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to perform so may be grounds for compensation. Our lawyers are operating difficult to get these hurt by the drug the compensation they are entitled to.

(Image: http://media2.picsearch.com/is?iliew5SWSrlFF1Mr0NIcAMawpBLzRbj0bVXFDyhruE4&height=228)Whilst bleeding can be a frequent complication connected with anticoagulants, it has been alleged that Xarelto is much more dangerous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, sufferers may possibly be at threat for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

If you or possibly a loved one particular suffered a significant bleeding occasion soon after taking Xarelto, you may have legal recourse. For a lot more data, contact us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenditures. Moreover, they may be searching for punitive damages, which are normally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding With xarelto, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for far more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

(Image: https://images59.fotki.com/v544/photos/2/3651632/13703394/Xareltolawsuit190515-vi.jpg)The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Discussion

Enter your comment (wiki syntax is allowed):

Personal Tools